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Preface 
Nordic co-operation is one of the world’s most extensive forms of regional 
collaboration, involving, Denmark, Finland, Iceland, Norway, and Sweden. Nordic co-
operation has firm traditions in politics, economics, and culture and plays an important 
role in the European and international collaboration. Nordic co-operation is built on 
common values and a willingness to achieve results that contribute to the development 
of a strong Nordic community in a strong Europe. The Nordic co-operation also aims at 
creating competencies and competitiveness in the global community.  
Nordic co-operation in nutrition has a long history with the main initial objective to 
determine the level of nutrient intake that would prevent nutrient deficiency disorders. 
Later, with the recognition of the needs to develop nutrient reference values that 
address optimal levels of nutrient intakes in relation to non-communicable diseases 
(NCDs) along with values to reduce the risk of toxic nutrient intakes, the Nordic 
countries developed a set of reference values, the Nordic Nutrition Recommendations.  
The Nordic Council of Ministers supports the task of setting the common Nordic 
Nutrition Recommendations, which have become a key document in the Nordic food-
nutrition-health area and related activities. The regional scientific forces have resulted 
in an overall Nordic action plan for “A Better Life through Diet and Physical Activity” 
and other activities. Along with the development of the nutrition sciences, the 
framework for developing nutrition reference values, and the increasing amounts of 
data available, it is relevant constantly to address the principles, the approaches, and 
the optimal use of the expertise and knowledge.  
The Nordic Council of Ministers provided funds through a grant from the Nordic 
Working Group for Diet, Food and Toxicology (NKMT) to a Project Team from the five 
Nordic countries: Inge Tetens, Professor, DK (project leader); Inga Thorsdoittir, 
Professor, IS; Liisa Valsta, Senior Scientist, FI, Hanna Eneroth, Risk-Benefit Assessor, 
Nutritionist and PhD, SE. The group discussed the current dual risk assessment 
approach in nutrition, including the practices, challenges and perspectives in relation to 
the setting of dietary reference values in the Nordic Nutrition Recommendations. To 
strengthen the Nordic capacity in the area and to enhance the transparency on 
pertinent issues, a Nordic symposium was held with invited guest experts and a broader 
audience. The symposium was hosted by “Vitality – Centre for good older lives” and 
Faculty of Science, University of Copenhagen. The present report summarizes this 
symposium.  
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Summary 
Nordic co-operation in the area of nutrition has a long history that includes the 
development and updates of the Nordic Nutrition Recommendations. As part of this 
continuous work, a Nordic project team organized with financial support from the 
NKMT a symposium on the dual risk approaches in nutrition.  
The purpose of the symposium was to discuss the current use and some of the 
challenges in applying a nutrition risk assessment approach in setting nutrition 
recommendations in the light of the forthcoming update of the Nordic Nutrition 
Recommendations (NNR).  
As the first speaker Inga Thorsdottir, IS reminded that the concept of a dual risk 
approach in nutrition stemmed from the potential risk of insufficient nutrient intakes at 
the low end and of toxic nutrient intakes at the upper end of the intake distribution 
range. The development of the NNR through the last almost 40 years reflects the 
increased awareness that a single figure of nutrient average requirement is insufficient 
to cover the variety of needs for reference values that could cover both the lower and 
higher nutrient intake levels. Inge Tetens, DK gave an overview of the terminology used 
in the Nordic dietary reference values which in many ways is similar to the terms 
adapted in other countries, regions, and international bodies – yet with important 
differences. The NNR do not include the term Adequate Intake (AI) but apply a Lower 
Intake Level (LI) that is defined differently compared with other reference values. The 
need for harmonization of terminologies was stressed. Anna Karin Lindroos, SE 
discussed the use of the LI value in the Nordic context and provided examples of 
assessments of inadequacy of selected micronutrient intakes using the LI cut-point and 
argued that the value is not needed for populations. Jan Alexander, NO, gave an 
overview of the Tolerable Upper intake Level (UL) that is the maximum level of total 
chronic daily intake of a nutrient judged to be unlikely to pose a risk of adverse health 
effects to humans. The UL is set to protect the population against adverse effects from 
high intakes of micronutrients. Examples on the derivation of ULs were provided for 
selenium and vitamin D through their biological adverse responses in relation to 
increasing intake. 
As part of selected current challenges in the dual risk assessment relevant for the 
Nordic countries Liisa Valsta, FI presented data on the use of food supplements that has 
increased considerably during the past decades in all the Nordic countries. 
Comparisons between countries of the contribution of supplements use to the total 
micro-nutrient intakes revealed large differences between countries and between 
sexes. Lotte Høgberg, DK gave a presentation of a recent Danish vitamin D intoxication 
outbreak among infants. The case demonstrated an example of a national collective 
risk assessment action and illustrated some of legislation challenges related to food 
supplements compared with registered pharmaceuticals. The case also demonstrated 
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the need for well-established routes of communication between health authorities and 
the health care system. 
Iodine is a nutrient that has achieved increased scientific awareness in the Nordic 
countries after a systematic review during the previous work for the NNR2012 revealed 
that the iodine status in the Nordic countries was generally not well documented. 
Ingibjorg Gunnarsdottir, IS and Helle Margrethe Meltzer, NO gave an overview of the 
Nordic situation and stressed how the Nordic co-operation had initiated new research 
activities with results that a least mild iodine deficiency exist in different population 
groups, among others pregnant women.  
The lack of data for deriving dietary reference values was addressed. Hildegard 
Przyrembel, DE explained how extrapolation from one group to another is often applied 
in relation to the setting of reference values. Extrapolation can be done in relation to 
body mass (isometric (linear) scaling) or energy expenditure (allometric scaling). The 
application of both methods was discussed in relation to nutrients.  
Some of the challenges in setting reference values for energy were presented by 
Monika Neuhaeuser-Berthold, DE. Daily energy expenditure varies relatively little 
within individuals, despite variation in physical activity but varies considerably among 
individuals even after controlling for body size. A major challenge is the setting of DRVs 
of energy for older adults due partly to a paucity of data regarding resting and total 
energy expenditure of those aged ≥ 80 years. The changes in body composition with 
ageing require special consideration and especially, physical activity levels of older 
adults likely to promote maintenance of muscle mass need to be identified.  
Tommy Cederholm, SE gave an overview of the NNR2012 protein 
recommendation for the elderly, where disease endpoints were also considered as a 
criteria. He argued that a low protein intake contributes to an insufficient muscle re-
modelling and muscle loss which again may lead to sarcopenia. To prevent such 
development, the NNR2012 increased the protein recommendation for older adults 
from 0.8 to 1–1.2 gram/kg body weight/day. It was stressed that a high protein intake 
may have negative effects on kidney function for certain groups with underlying 
diseases.  
Elizabeth Yetley, US summarized how the committees convened by the U.S. 
Institute of Medicine historically have used a dual risk assessment approach to 
determine Dietary Reference Intakes (DRIs). A recent report recommended guiding 
principles for incorporating chronic disease endpoints into future DRI evaluations, with 
the key questions if there is a causal relationship between the nutrient and chronic 
disease(s), and, if so, what the nature of the quantitative intake-response curve is.  
Rune Blomhoff, NO summarized his impressions of the day by expressing the 
appropriateness of the symposium as it addressed topics pertinent to the forthcoming 
update of the Nordic Nutrition Recommendations. He underlined the need for 
harmonization, the specific Nordic challenges, and the stimulating thoughts in relation 
to the approaches currently applied and the future opportunities.  
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In her closing remarks, Inge Tetens thanked the many excellent presentations from 
the invited experts and good discussions. She expressed confidence that the 
symposium had fulfilled its tasks – to contribute to the strengthening of the capacity of 
the Nordic experts involved in the forthcoming update of the NNR and to enhancing 
the transparency of the dual risk assessment approach in nutrition.  
12 The Dual Risk Approach in Nutrition 
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1. Background and purpose of
symposium
The classical risk assessment approach offers a highly systematic framework within 
which information can be organized and evaluated. Contrary to non-nutrients, 
nutrients have a dual risk with a health risk at the low nutrient intake range (deficiency) 
and a risk at the high end of the nutrient intake range (toxicology).  
The purpose of the symposium is to discuss the current use and some of the 
challenges in applying a nutrition risk assessment approach in setting nutrition 
recommendations in the light of the forthcoming update of the Nordic Nutrition 
Recommendations (NNR).  
At the symposium invited experts address the methodological framework from the 
classical risk assessment approach as a basis for addressing the risk approach for setting 
nutrition recommendations and in particular for setting the criteria for the nutrient risk 
assessment. Case studies from the Nordic countries are presented to underline some of 
the challenges in applying the risk assessment approach. Especially, the choice of criteria 
and the lack of data for risk assessment in nutrition are addressed with examples on 
extrapolations to subgroups like children and elderly and the challenges in setting 
reference values for energy and protein with examples from the ageing population. 
Finally, the development of nutrition risk assessment using nutrient intakes and chronic 
disease endpoints is discussed. 
Figure 1: The framework for the dual risk approach in nutrition 
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This report presents abstracts with highlights of the key points presented by the invited 
speakers. The discussions following the presentations are summarized in short with 
questions (Q), answers (A) and comments (C).  
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2. The Dual Risk approach in
Nutrition – the concept,
terminologies and approaches
2.1 Introduction to the Dual Risk concept in nutrition 
Inga Thorsdottir, Professor, Dean, School of Health Sciences, University of Iceland, Iceland 
Nutrition researchers have strived to define the optimal intake of nutrients for decades. 
The physiological roles of nutrients have served as the theoretical basis and 
measurements or calculations of the body’s needs, usage and storage of single 
nutrients have been used as criteria to define the optimal intake. Recommendations for 
single nutrients build on defined optimal intakes with additional safety factors.  
The development of the science of nutrition includes the use of a dual risk approach 
methodology, where both too low and too high intake levels of exposures are 
considered for potential adverse health effects. The focus is on the scientific evidence 
for various outcomes, e.g. non-communicable diseases, additionally to nutrient 
deficiency and toxicity, and body weight and growth.  
The 5th edition of the Nordic Nutrition Recommendations (NNR2012) refers to a 
set of dietary reference values (DRVs) for essential nutrients and reference values for 
energy intake and physical activity. Food-based dietary guidelines (FBDG) are based on 
DRVs and evidence for health effects of food, while sustainability and environmental 
issues play a growing role. The 6th ed. of NNR is timely and will continue to serve as 
basis for health and nutrition promotion initiatives, aiming to improve public health in 
the Nordic countries through improvement of diet. Growth of scientific knowledge and 
challenges in the environment, food systems, and habits demand update of the NNR 
evidence. Methodological ways to work on the evidence-based recommendations are 
constantly improved. Further implementation of the NNR has to be strengthened. 
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2.2 Terminologies in nutrition risk assessment 
Inge Tetens, Professor in Nutrition and Ageing, Vitality – Centre for good older lives, 
Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark 
In the Nordic countries Dietary Reference Values (DRV) are used as the umbrella term 
for a complete set of nutrient references values. An overview of the terminologies used 
in the various versions of the Nordic Nutrition Recommendations (NNR 1 through 5) 
from 1980 to 2012 reflects an increased awareness that a single figure of nutrient 
average requirement is insufficient to cover the variety of needs for reference values 
that could cover both the lower and higher nutrient intake levels and that an 
assessment of the distribution of requirements for each nutrient would be beneficial.  
In the Nordic context the term Dietary Reference Values (DRVs) denote the 
individual values: average requirements (AR), recommended intake (RI), upper intake 
level (UL), lower intake level (LI), reference values for energy intake and recommended 
intake range of macronutrients (Table 1).  
Table 1: Terminologies used in nutrition risk assessment in the Nordic countries and other parts of the 
world 
Nordic countries  
(2012) 
WHO/FAO  
(2004) 
UK  
(1991) 
US &Canada  
(1994–2004) 
WHO  
(2007) 
European 
Commission 
(EFSA)  
(2010) 
DRV 
(Dietary reference 
values) 
DRV 
(Dietary reference 
values) 
DRI 
(Dietary reference 
intakes) 
NIV 
(Nutrient intake 
values) 
DRV 
(Dietary reference 
values) 
RI 
(Recommended 
intake) 
RNI 
(Recommended 
nutrient intake) 
RNI 
(Reference 
nutrient intakes) 
RDA 
(Recommended 
dietary 
allowance) 
INLx 
(Individual 
nutrient levelx) 
PRI 
(Population 
reference intake) 
AR 
(Average 
requirement) 
Basal and 
normative 
nutrient 
requirements 
EAR 
(Estimated 
average 
requirement) 
EAR 
(Estimated 
average 
requirement) 
ANR 
(Average nutrient 
levelx) 
AR 
(Average 
requirement) 
Safe Intake  AI 
(Adequate intake) 
AI 
(Adequate intake) 
LI  
(Lower intake 
level) 
LRNI 
(Lower reference 
nutrient intake) 
LTI 
(Lower threshold 
intake) 
UL  
(Upper intake 
level) 
UL  
(Upper tolerable 
nutrient intake 
level) 
UL  
(Tolerable upper 
intake level) 
UNL 
(Upper nutrient 
level) 
UL 
(Tolerable upper 
Intake level) 
RI  
(Recommended 
intake ranges for 
macronutrients) 
AMDR 
(Adequate 
macronutrient 
distribution 
range) 
Individual 
minimum, 
maximum, and 
population 
averages 
AMDR 
(Adequate 
macronutrient 
distribution 
range) 
RI  
(Recommended 
intake ranges for 
macronutrients) 
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The Nordic terminology is in many ways similar to the terms adapted in other countries, 
regions, and international bodies. Yet, there are also important differences. Compared 
with other sets of reference values, the Nordic terminology does not include the term 
Adequate Intake (AI). AI was defined earlier by IoM and EFSA as a proxy of a 
recommended nutrient intake, applied when an average requirement cannot be 
determined due to lack of appropriate data. The AI is therefore typically applied when 
data from observed or experimentally determined estimates of nutrition intakes by a 
group of people are available.  
As the use of data from observational studies and the use of biomarkers becomes 
more prevalent as a base for setting the DRV, careful considerations and decisions are 
needed as to the optimal approach for obtaining valid scientifically grounded and 
transparent values on the relationship between nutrient intakes and adequacy and/or 
health outcomes. The different terminologies used by national, regional or 
international agencies/bodies lead to considerable confusions, misunderstanding and 
even worse, misinterpretation. This has led to the common notion that harmonization 
of the terminologies would be warranted and various attempts have been done. 
Recently, a workshop held by the WHO, FAO, UNU, and the FNB of the National 
Academies of Sciences, Engineering, and Medicine was organized to explore the 
evidence for achieving global harmonization of methodological approaches to 
establishing nutrient recommendations.1 Until harmonization occurs, the reference 
values should be interpreted and used carefully. 
2.3 The approach and use of the lower intake level (LI) – can we 
do without it? 
Anna Karin Lindroos, PhD and Senior lecturer, the National Food Agency, Uppsala and 
Department of internal medicine and clinical nutrition, Sahlgrenska Academy, University 
of Gothenburg, Sweden 
The primary reference value for assessing adequacy of micronutrient intake of defined 
groups is average requirement (AR). Mean reported intake in a survey can be compared 
with AR if the intake distribution is similar to the requirement distribution. This is true 
for many nutrients, but not all. Values for RI, LI and UL can complement the nutrient 
intake assessment. This presentation will focus on LI.  
Already in 1971, a three-step approach to assess dietary intake was suggested by 
Eeg-Larsen, Isaksson, Nikolaysen and Wretlind in the report “Veiledning til vurdering of 
planlegging av kosthold” published as an appendix to Näringsforskning. The lowest 
step, “minimum verdi”, is the cut-off value below which an intake would lead to 
1 National Academies of Sciences, Engineering, and Medicine. (2018). Global harmonization of methodological approaches to 
nutrient intake recommendations: Proceedings of a workshop—in brief. Washington, DC: The National Academies Press. doi: 
https://doi.org/10.17226/24989 
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deficiency symptoms. This value could give an indication of risk of deficiency, but 
biochemical and clinical measurements have to be included in order to establish if the 
intake of a specific nutrient is too low or not. Based on the Eeg-Larsen report, LI was 
included in the first edition of the Nordic Nutrition Recommendations (NNR) and have 
since then been included in all the NNR editions.  
However, lower intake levels are not commonly used outside the Nordic countries. 
In the IOM Dietary Reference Values for USA and Canada there are no values for lower 
intake levels and it is recommended that AR and percentiles are used in the assessment 
of micronutrient intake. Many countries use the IOM recommendations for assessing 
nutrient intake. In the UK – Lower Reference Nutrient Intake (LRNI) are used together 
with AR when nutrient intakes are assessed in the National Diet and Nutrition Survey. 
The LRNI are derived from (AR – 2 SD) and are thus not established in the same way as 
in the NNR, although in practice the LRNI and LI values are similar.  
Examples of assessing inadequacy of selected micronutrient intakes using the NNR 
approach including LI cut-points and the IOM approach using the AR (or EAR) cut-point 
method are given, using data from Swedish women. Table 2 shows that proportions 
below LI did not add much additional information for vitamin D and calcium. Thus, LI 
values may not be needed for most micronutrients when evaluating intake in the Nordic 
populations.  
Table 2: Distribution of selected micronutrient intakes and assessment of inadequate intake by 
proportions below the LI and AR cut-offs in 838 women in the Swedish National Dietary Survey  
2010–2011 
Folate Intake  
(µg/day) 
Vitamin D  
(µg/day) 
Calcium  
(mg/day) 
P5 129 2.23 459 
P25 189 3.90 672 
P50 237 5.82 849 
P75 294 8.57 1,032 
P95 405 14.7 1,369 
AR 200 µg/day 7.5 µg/day 500 mg/day 
% < AR 18 % 56 % 5 % 
95 % CI 16; 20 53; 59 3.8; 6.6 
% < LI 0.1 6 2 
2.4 The approach in setting the upper level (UL) – methodologies 
and issues to address 
Jan Alexander, Norwegian Institute of Public Health, Oslo, Norway 
Like other chemical substances, vitamins and minerals (as well as other nutrients) may 
have adverse effects if consumed in excessive amounts (Figure 2). The purpose of 
setting Tolerable upper intake levels (UL) is to protect the population against adverse 
effects from high intakes of micronutrients. The UL is the maximum level of total 
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chronic daily intake of a nutrient judged to be unlikely to pose a risk of adverse health 
effects to humans.  
“Tolerable intake” in this context connotes what is physiologically tolerable and is 
a scientific judgement as determined by assessment of the probability of an adverse 
effect at a given intake. The UL is not a recommended level of intake. It is an estimate 
of the highest level of intake, which carries no appreciable risk of adverse health effects. 
For nutrients, no risk of adverse effects is expected unless a threshold intake, which vary 
among individuals, is exceeded. 
Figure 2: Responses of biological systems (beneficial responses not included) 
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Figure 3: Dose-effect relationships for vitamin D and for selenium 
Note: PTH=parathyroid hormone; ALAT=alanine amino transferase. 
ULs are established close to the low end of the theoretical distribution of thresholds 
adverse effects. The challenge is to determine this value. Steps in the establishment of 
a UL include Hazard identification and Hazard characterisation. Preferably, human data, 
but also animal data may be used to identify evidence of adverse effects that is causally 
related to the exposure. Not all effects may be adverse, e.g. biomarkers, but some can 
be directly or indirectly linked to an adverse effect. Experimental data from animals or 
in vitro may be used to complement human data and provide valuable mechanistic 
information. The next step is Hazard characterisation, which includes dose-response 
assessment of the critical end-point and derivation of a reference point, a benchmark 
dose lower confidence level (BMDL) or no observed adverse level (NOAEL)/lowest 
observed adverse effect level (LOAEL), from which the UL is established.  
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Because major limitations are imprecision, lack and limited adequacy of the data 
on variability, uncertainty factors are used. For interspecies variation, a factor of 10 is 
used as a default value, but this may be lower if the data also cover the most susceptible 
individuals. In the absence of specific data, a default factor of 10 is used for 
extrapolation from animal to human data. Vitamin D and selenium will be presented as 
examples of the setting ULs (Figure 3).  
2.5 What are the implications for NNR? Time for Q/A’s  
 Q: Do you think it is problem that we use two different levels of assessing 
adequate intake? We use the median intake as a reference for energy and range 
for macro-nutrients, but we use the average requirement for micronutrients. Does 
this not create a problem?  
 A: We use the average requirement when assessing the micronutrient intake 
of diets of groups of people rather than using recommended intake (RI), 
because the RI is meant to cover the majority of that group. If we use the RI, 
we will overestimate the proportion of individuals with an inadequate nutrient 
intake.  
 Q: Is it true that for certain micronutrients there is no upper limit? And does this 
mean that these nutrients are safe to consume even in very large quantities, for 
instance, via highly concentrated supplements? Should we not be cautious?  
 A: The upper limits are based on evidence, and if the evidence is non-existing 
then these upper limits cannot be set. We have to advise as best as possible.  
 A: Yes, we should be cautious. I will give you an example of two nutrients that 
were first perceived to be harmless even in high concentrations. For many 
years it was assumed that beta-carotene and vitamin E had no upper level, 
but we later learned through clinical trials that both vitamins in larger doses 
have detrimental health effects – both increase the risk of different cancers. 
So, I think it is safer to assume that all micronutrients have an upper level 
even though we do not know this number. 
 Q: Are the UL values based on evidence from supplements, from food or both? 
Does this have any implication? This seems to be confusing, because what 
amount can come from the diet? Do you think that the NNR should work more on 
including evidence from both food and supplements? 
 A: I think NNR should work towards including upper limits for all nutrient 
sources. Most of the evidence is based on supplement studies, but also on 
other sources and on extrapolations. For iron, for instance, the upper limit is 
based on supplements, so it is difficult to set the upper limit for both food and 
supplements (a total upper limit). Discussing upper limit for fluorine, sources 
such as toothpaste has also been considered. 
 Comment: Moving forward, we should think more about the users of these 
reference values. I will give you two examples which are confusing to people. The 
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usage of average requirement, which cannot be used to assess populations, and 
secondly, some people are confused by the fact that Dietary Reference Values 
(DRVs) are sometimes given as intervals. 
 Q: Do you know the distribution for iron requirements?
 A: Iron requirements are not normally distributed, since the requirements are
different for different age groups, particular for fertile women.  
 Q: In Brazil we use the UL for sodium instead of the average requirement (AR),
because almost all Brazilians have an intake above AR. What do you think of this
method?
 A: Since sodium is an essential nutrient we have both an AR and UL for
sodium intake (in the US, ed). It is worrying that the sodium intake is at such a 
high level that you have to use the UL to assess the risk of excessive sodium 
intake in Brazil. (In the NNR2012, the DRV for sodium is expressed as a 
“population goal”, ed). 
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3. Current Challenges in Dual Risk
assessment in Nutrition
3.1 Nutrient intakes from supplements vs intakes from diets in 
the Nordic Countries? 
Liisa Valsta, Research Manager, Adjunct Professor, Finnish National Institute for Health 
and Welfare (THL), Department of Public Health Solutions, Public Health Promotion Unit, 
Finland 
The availability and use of food supplements has increased considerably during the past 
decades in the Nordic Countries. The most recent supplement use and nutrient intake 
data are available from most of the national dietary surveys carried out in all Nordic 
countries between 2010–2013. Inclusion and coverage of food supplements in the 
national food composition databases have improved since early 1990s but varies still 
between countries from less than 100 supplement codes to around 1,000 codes with 
values available for micro-nutrient intake estimations.  
In all other countries but Sweden, the prevalence of food supplement use varied in 
these studies around 50% among men (43–63%) and around 65% among women (58–
71%). The prevalence in Sweden seemed to be lower (Figure 4). In certain population 
groups (e.g. among 11–50 years old Danes), the nutrient intake from food among 
supplement users exceeded that of nutrient intake from food of non-consumers, but 
not in all populations (e.g. among Finnish and Swedish adults).  
Food supplements have shown to contribute to higher intakes of vitamins A, D and 
E, pyridoxine, iron and selenium among adolescents and young adults in Denmark. In 
addition to the listed nutrients, among Swedish adults also intakes of thiamine (over 3-
fold), niacin, folic acid, vitamin-B12 (over 6-fold), vitamin C, calcium, magnesium, zinc 
have shown to be higher among supplement users compared to non-users. Similar 
pattern is seen also in Finland with over 2-fold intakes of thiamine, riboflavin, 
pyridoxine, vitamin B12 among both men and women using supplements and among 
men also in intakes of Vitamin C and magnesium compared to non-users. In Iceland, the 
additional micro-nutrient intake as % from food supplements compared to the intake 
from foods varies between 10–70%. The largest contributions (>40%) are seen in 
intakes of vitamin E, vitamin B6, vitamin C and molybdenum. In Norway, intakes of 
vitamins D, E and C are higher among men and women using supplements and vitamin 
C and iron intakes among women using supplements, but the increases in intakes have 
been moderate. Retinol, iron, zinc intakes among Danish children, pyridoxine, zinc and 
calcium intakes among Finnish adults and pyridoxine, folic acid, vitamin C and iron have 
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shown to exceed the Tolerable Upper Intake Limit (UL) due to supplement use, but 
usually only in a small proportion of the population. 
Figure 4: Proportion of adults in the Nordic countries using food supplements 
Source: DANSA 2010–13, FINDIET 2012, National Icelandic Dietary Survey 2010–2011, Norkost 3, 2011, 
Riksmaten 2010–2011 (partly unpublished data). 
Comparison of contributions of supplement use to micro-nutrient intakes between 
countries include uncertainties due to differences in data collection methods, reference 
period and frequency of supplement use in focus. 
3.2 Infants and vitamin D intoxication, recent outbreak in DK 
Lotte CG Hoegberg, on behalf of the National Vitamin D outbreak Workgroup 
The National Vitamin D outbreak Workgroup are: Søren Bøgevig (1), Lotte Hoegberg Cg 
(2), Anders Schou J (3), Ida Schmidt M. (4), Fie Vojdeman J. (5), Konstantinos Kamperis (6), 
Christian Mølgaard (7), Christine Brot (8), Henrik Christesen (3).  
(1) Department of Clinical Pharmacology, The Danish Poisons Information Center,
Copenhagen University Hospital Bispebjerg, (2) Department of Anaesthesiology, The 
Danish Poisons Information Center, Copenhagen University Hospital Bispebjerg, (3) Hans 
Christian Andersen Children’s Hospital, Odense University Hospital, (4) Department of 
Paediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, (5) 
Department of Clinical Biochemistry, Copenhagen University Hospital Bispebjerg, (6) 
Department of Paediatrics, Aarhus University Hospital Skejby, (7) Department of 
Nutrition, Exercise and Sports, University of Copenhagen, (8) Danish Health Authority, 
Denmark. 
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Subtitle: National vitamin D intoxication outbreak among infants due to a manufacturing 
error of vitamin D droplets: Challenges for the health care system. 
Objective: Danish Health Authorities (DHA) recommend vitamin D 
supplementation for children up to two years with 10 micrograms (400 IU)/day, equal 
to five droplets of 2 microgram/droplet. An erroneous manufactured vitamin D product 
was identified in July 2016 after an infant had developed severe vitamin D intoxication, 
despite a daily dose of the recommended five drops. We describe the first 10 days of 
the outbreak and identify risk assessment and risk communication between involved 
physicians from The Danish Poisons Information Centre (DPIC), The Danish Paediatric 
Society (DPS) and DHA. 
Case Series: Laboratory analysis performed by the Danish Veterinary and Food 
Administration showed that the specific vitamin D product contained 150 
microgram/droplet instead of the intended 2 microgram/droplet. Infants dosed as 
recommended therefore received 750 micrograms (30,000 IU) daily. There was no 
concentration stated on the label. The manufacturing company acclaimed the 
production of 500 bottles (each 10 ml) due to a human error in the manufacturing 
process. The product was immediately withdrawn. A total of 340 bottles were already 
sold from March 2016.  
Nine days after withdrawal of the product the DHA had identified 150 children <2 
years at risk of intoxication. Of those 87 children had already been diagnosed with s-25-
hydroxy vitamin D >150 nmol/L. Serum ionized calcium >1.35 mmol/L was detected in 
76 infants, and 18 infants had severe hypercalcemia with ionized calcium of >1.49 
mmol/L. Symptoms included reduced appetite, vomiting, irritability and failure to 
thrive. A few patients had severe symptoms. We developed an urgent national tracing, 
diagnosis and treatment algorithm for vitamin D intoxication. Warnings and public 
emergency announcements were issued from the DHA and a strategy for keeping the 
media attention to the matter was made between DPIC, DPS and DHA to ensure 
identification and management of all exposed infants.  
Conclusion: The outbreak occurred in the summer holiday and our collective risk 
assessment drew attention to the importance of thorough medical examination of all 
exposed patients, preferably in a hospital setting. Errors in distribution of important 
information regarding triage and treatment according to new guidelines within the 
healthcare system were seen in numerous situations in the first days. This case series 
illustrate the legislation challenges by categorization of potentially toxic substances 
as food supplements instead of registered pharmaceuticals and the need for well-
established routes of communication between health authorities and the health care 
system. 
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3.3 Pregnancy/lactation and iodine, recent situation in Nordic 
countries 
Ingibjörg Gunnarsdóttir, Unit for Nutrition Research, Faculty of Food Science and 
Nutrition, University of Iceland & Landspitali National University Hospital, Island  
Presented by Helle Margrete Meltzer, Research director, Management and Staff for 
Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, 
Norway 
 
 
A number of systematic literature reviews formed the basis for establishment of dietary 
reference values in the 5th edition of Nordic Nutrition Recommendations (NNR) 2012. 
In one of them, recent scientific data on health effects of iodine status (as an indicator 
of iodine intake) was reviewed. Pregnancy is one of the most critical periods for iodine 
deficiency where inadequate maternal iodine status might have adverse effects on fetal 
neurodevelopment.  
One of the main results of the systematic review Iodine intake in human nutrition for 
the 5th edition of the NNR was that the iodine status in the Nordic countries was in 
general not well documented. At the time, the majority of studies in the area of iodine 
nutrition from the Nordic countries were from Denmark. Following discussions on the 
situation at the 10th Nordic Nutrition Conference in Reykjavik 2012 were the 5th edition 
of the NNR were presented, a small group of scientists gathered to establish a Nordic 
collaboration aiming at encouraging studies in this field. The first Nordic Iodine meeting 
took place in Gothenburg in October 2013, followed by meetings in Copenhagen 2014, 
Bergen in 2015 and Reykjavik 2017.  
Since 2012 the number of publications in the area of iodine nutrition from the 
Nordic countries has increased considerably, and we now have data suggesting at least 
mild iodine deficiency in many different population groups in the Nordic countries, 
including pregnant women.  
Below is a selection of Nordic articles published since 2012. 
 
Box 1: List of references from Nordic countries on iodine nutrition 
I. Gunnarsdottir I, Gustavsdottir AG, Steingrimsdottir L, Maage A, Johannesson AJ, Thorsdottir I. 
Iodine status of pregnant women in a population changing from high to lower fish and milk 
consumption. Public Health Nutr. 2013 Feb;16(2):325-9. 
https://www.ncbi.nlm.nih.gov/pubmed/22607718 
 
II. Brantsæter AL, Abel MH, Haugen M, Meltzer HM. Risk of suboptimal iodine intake in pregnant 
Norwegian women. Nutrients. 2013 Feb 6;5(2):424-40. 
https://www.ncbi.nlm.nih.gov/pubmed/23389302 
 
III. Granfors M, Andersson M, Stinca S, Åkerud H, Skalkidou A, Poromaa IS, Wikström AK, Nyström 
HF. Iodine deficiency in a study population of pregnant women in Sweden. Acta Obstet Gynecol 
Scand. 2015 Nov;94(11):1168-74. https://www.ncbi.nlm.nih.gov/pubmed/26292156 
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IV. Kirkegaard-Klitbo DM, Perslev K, Andersen SL, Perrild H, Knudsen N, Weber T, Rasmussen LB,
Laurberg P. Iodine deficiency in pregnancy is prevalent in vulnerable groups in Denmark. Dan Med J. 
2016 Nov;63(11). https://www.ncbi.nlm.nih.gov/pubmed/27808034 
V. Henjum S, Lilleengen AM, Aakre I, Dudareva A, Gjengedal ELF, Meltzer HM, Brantsæter AL.
Suboptimal Iodine Concentration in Breastmilk and Inadequate Iodine Intake among Lactating 
Women in Norway. Nutrients. 2017 Jun 22;9(7). https://www.ncbi.nlm.nih.gov/pubmed/28640217 
VI. Abel MH, Caspersen IH, Meltzer HM, Haugen M, Brandlistuen RE, Aase H, Alexander J, Torheim LE,
Brantsæter AL. Suboptimal Maternal Iodine Intake Is Associated with Impaired Child 
Neurodevelopment at 3 Years of Age in the Norwegian Mother and Child Cohort Study. J Nutr. 2017 
Jul;147(7):1314-1324. https://www.ncbi.nlm.nih.gov/pubmed/28515161 
VII. Abel MH, Ystrom E, Caspersen IH, Meltzer HM, Aase H, Torheim LE, Askeland RB, Reichborn-
Kjennerud T, Brantsæter AL. Maternal Iodine Intake and Offspring Attention-Deficit/Hyperactivity 
Disorder: Results from a Large Prospective Cohort Study. Nutrients. 2017 Nov 13;9(11). 
https://www.ncbi.nlm.nih.gov/pubmed/29137191 
VIII. Brantsæter AL, Knutsen HK, Johansen NC, Nyheim KA, Erlund I, Meltzer HM, Henjum S.
Inadequate Iodine Intake in Population Groups Defined by Age, Life Stage and Vegetarian Dietary 
Practice in a Norwegian Convenience Sample. Nutrients. 2018 Feb 17;10(2). 
https://www.ncbi.nlm.nih.gov/pubmed/29462974 
IX. Henjum S, Aakre I, Lilleengen AM, Garnweidner-Holme L, Borthne S, Pajalic Z, Blix E, Gjengedal 
ELF, Brantsæter AL. Suboptimal Iodine Status among Pregnant Women in the Oslo Area, Norway. 
Nutrients. 2018 Feb 28;10(3). https://www.ncbi.nlm.nih.gov/pubmed/29495606 
3.4 What are the implications for NNR? Time for Q/A’s 
3.4.1 Q/A’s re nutrient intakes from supplements 
 Q: It must be complicated to assess the nutrient intake from foods, fortified foods
and dietary supplements? How is this done? 
 A: We take into account intakes from both foods, fortified foods and 
supplements. But it would be interesting to see the whole picture and be able 
to take into account the bioavailability of nutrients, which could be different 
in fortified foods compared and non-fortified foods. Also, it would be 
interesting to compare the fortification practices in different countries.  
 Q: Can you comment on the high vitamin D intake in Finland?
 A: We fortify a range of different food products with vitamin D in Finland, for
instance, both skim and fatty milk, yoghurt and spreads. So, these fortified 
food products are probably explaining the high vitamin D intake in Finland.  
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3.4.2 Q/A re vitamin D intoxication 
 Q: How did this product (vitamin D supplement, ed.) end up on the market – is
there no control of food supplements in Denmark? 
 A: Anyone can produce supplements in Denmark and this production is not
subjected to the same strict production criteria, as is the case for medical 
products. For instance, they only need to test the concentration in relatively 
few random samples, not in every batch produced. We should perhaps 
reconsider this practice to avoid these types of accidents. This product was 
not sold in a pharmacy, which typically has a strict product control. It was only 
sold in physical or online health food stores.  
 Q: So the manufacture is not liable? 
 A: Yes, certainly they are. 
 Q: Did this case make international news because other countries could learn from 
this incidence. Informing other countries could be important since this learning
about this event could perhaps prevent it from happening in other places. 
 A: Yes, it made both European and North American news, so a lot of
international attention was brought on by this incident.  
 C: There are few cases in the history concerning vitamin D intoxication, but yours
seem to be unique since the exposure were vitamin D alone, not in a combination
with other nutrients.
 A: Yes, but we have done a literature search regarding relevant studies and 
will compare these data to our own. A scientific article will be published 
sometime in the future. 
3.4.3 Q/A re iodine during pregnancy/lactation 
 Q: In case of the “correlation between low iodine and ADHD/low IQ” – is there any
causal evidence of the relationship?
 A: This is based on observational studies. We have of course corrected for
potential confounders, but we never know for sure with this type of evidence. 
However, there is a British study (ALSPAC study) indicating the same – low 
iodine concentration in pregnant women and low IQ score in their offspring, 
and more studies are coming from Norway that are showing similar results.  
 Q: Is it correct that there is no fortification of salt with iodine in Norway and 
Iceland, while this is the practice in Finland, Denmark and Sweden?
 A: We have very different practices in the Nordic countries when it comes to
fortification of foods. For instance, Norway has 10 times less iodine in their 
salt compared to Sweden – 5 µg vs. 50 µg per gram of salt. Iceland (like 
Denmark, Norway and Sweden, ed) has both fortified and non-fortified salt. In 
Finland they have 25 µg per 1 gram of salt. So, despite the similarities 
between our countries, there are large differences in how we fortify our salt. 
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In Norway the National Nutrition Council has recommended the Norwegian 
government to do something about the low iodine intake in Norway, but we 
also have to consider the potential negative consequences of such actions. 
For instance, many two-year olds already have an intake above what is 
recommended in Norway due to high milk consumption. Fortification is 
therefore a balance. We have to make sure that we are not increasing the 
number of children that are reaching the UL for iodine due to fortification. In 
general, we have to be cautious because there is a relatively narrow gap 
between recommended intake and the UL for iodine.  
 Q: Should we not focus more on recommending iodine for pregnant women when
we know they are likely to be a high-risk group?
 A: We do not have data for all of the population and some of the data we have
indicate that iodine supplementation in pregnant women has no effect. 
Increasing iodine intake in pregnant women with low iodine concentrations 
can shock the “thyroid system” and even have the opposite effect. So we have 
to be careful in regards to recommending iodine intake in pregnant women 
even though they might have a low iodine intake.  
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4. Filling the Data Gaps –
extrapolations
4.1 Extrapolations – allometric or isometric scaling? 
Hildegard Przyrembel, Germany 
Dietary reference values (DRVs) are often set based on data from particular population 
groups characterised according to age, sex and possibly also environmental conditions. 
For population groups for which data are lacking or which differ in characteristics 
extrapolation is needed to arrive at DRVs (rarely interpolation between two adjacent 
population groups).  
Extrapolation can be done in relation to body mass or, less often, in relation to 
energy expenditure (expressed as nutrient density, e.g. niacin). Not all nutrients are 
equal! There are those whose requirement is apparently proportionate to total body 
mass (e.g. potassium as considered by EFSA) and there are those whose requirement is 
not proportionate to total body mass but assumed to be proportionate to the sum of 
masses of metabolically most active organs/tissues.  
In the first instance we speak of isometric (linear) scaling, in the second of 
allometric scaling, using body mass with an exponent, mostly of 0.75 (e.g. most 
vitamins of the B group). Because the relationship of metabolically most active 
organs/tissues (liver, brain, kidney, intestine) to total body mass changes during growth 
and development (as does also the relationship of metabolically less active 
organs/tissues, such as muscle, adipose tissue) presumably the appropriate exponent 
to body mass changes too (Figure 5).  
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Figure 5: Differences in body proportions between a new-born and an adult 
Source: Adapted from Valentin, J. (ed.). Annals of the ICRP: Basic Anatomical and Physiological Data for Use 
in Radiological Protection: Reference Values. Published for The International Commission on 
Radiological Protection by PERGAMON, 2003. Elsevier Science Ltd., fig. 4.9, p.82: “Right lateral 
views of the newborn infant and adult male reconstructed to the same height (Scammon, 1953).  
(a) The skeleton, (b) the musculature, subcutaneous tissue, and skin, and (c) the major visceral 
mass and the central nervous system.” Only panel c is presented here. Licensed under Creative 
Commons Attribution-Sharealike 3.0 Unported and GNU Free Document. 
The fact is, that we know little about the correctness of these assumptions: 1) the 
appropriate exponent for body mass and 2) which nutrients require allometric scaling 
and how can we prove it. For demonstration of this uncertainty, the scaling procedures 
performed by the USA FNB and by EFSA are shown in comparison.  
Table 3: Comparison of the scaling approach used by the FNB of the IoM and EFSA (different 
approaches in italics) 
FNB EFSA 
Isometric scaling Minerals Calcium, fluoride, magnesium, 
manganese 
Calcium, fluoride, iodine, magnesium, 
manganese, molybdenum, potassium, 
selenium 
Isometric scaling Vitamins Niacin, thiamin, vitamin C, vitamin E 
Allometric scaling Minerals Chronium, copper, iodine, molybdenum, 
selenium, zinc 
Copper 
Allometric scaling Vitamins Biotin, thiamin, choline, niacin, vitamins 
B2, B6, B12, A, C, E, K, folate, pantothenic 
acid 
Biotin, vitamins A, B2, B6, B12, C, E, K, 
folate, pantothenic acid, choline, folate 
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4.2 Challenges in setting reference values for energy 
Monika Neuhäuser-Berthold, Institute of Nutritional Science, Justus Liebig University, 
Giessen, Germany 
Dietary reference values (DRVs) of energy for adults aim to maintain a body mass that 
has been associated with lowest morbidity and mortality. Such values are based on 
measurements of either total energy expenditure using the doubly labelled water 
method or of the various components of energy expenditure using indirect calorimetry 
and the factorial approach in reference populations. Both techniques have specific 
advantages and disadvantages.  
Although it is recognized that, beside body mass body composition is the major 
determinant of energy expenditure, the extent to which variation in the energy 
expenditure of individual tissues and organs can explain the diversity in energy 
expenditure among individuals needs to be further explored. It has been observed that 
daily energy expenditure varies relatively little within individuals, despite variation in 
physical activity and that it varies considerably among individuals even after controlling 
for the effect of body size. This suggests that energy expenditure is controlled at an 
individual set-point for energy expenditure. In how far genetics and metabolic 
processes such as adaptive thermogenesis may be involved in the regulation of energy 
expenditure awaits further elucidation.  
A major challenge is the setting of DRVs of energy for older adults who are 
considered as the fastest growing segment of the population. There is a paucity of data 
regarding resting and total energy expenditure of those aged ≥ 80 years. Aging is 
generally associated with an increase in body mass until an age up to about 70 years, 
when it begins to decline. There is also a progressive decline in energy intake and daily 
total energy expenditure. Characteristic changes in body composition during the 
course of aging are an increase in fat mass with a greater proportion of abdominal and 
visceral fat while muscle mass decreases. These changes require special consideration 
in the derivation of DRVs of energy for this age group and especially, physical activity 
levels of older adults likely to promote maintenance of muscle mass need to be 
identified.  
Table 4: DRVs and energy intake for the ageing population 
DRVs and energy intake for the ageing population
There is uncertainty about the target BMI in older adults 
Several studies have reported an attenuation of the U- or J-shaped BMI mortality curves 
Some studies have reported a minimum mortality at higher BMI in older subjects than younger subjects 
Recent Opinions on DRVs of energy from EFSA (2013) and D-A-CH (2015) did not include specific BMI ranges for older 
because of the evidence for this was considered insufficient 
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Facing the increasing prevalence of overweight and obesity, the role of energy 
expenditure, with regard to energy imbalances cannot be regarded independently from 
energy intake. Methods allowing accurate energy balance studies may contribute to a 
better understanding of the underlying mechanisms that lead to changes in body mass 
and body composition in individuals. 
4.3 Elderly and protein recommendation – when disease 
endpoints are also considered 
Tommy Cederholm, MD, PhD, Professor, Clinical Nutrition and Metabolism, Uppsala 
University, Theme Ageing, Karolinska University Hospital, Sweden 
 
 
Protein is a nutrient with the potential to impose health risks when intake is high as well 
as low. Furthermore, a reduced protein intake may be linked both to detrimental as well 
as under some conditions beneficial effects.  
In older people a low protein intake contributes to an insufficient muscle re-
modeling and muscle loss. When muscle mass reduction passes a certain degree muscle 
function is at stake, leading to sarcopenia. In general, people tend to reduce their 
protein intake with increasing age. Protein deficiency is one possible reason for 
sarcopenia, which contributes to the development of frailty, a less independent life-
style and eventually to disability. In order to prevent such development, the previous 
NNR2012 increased the protein recommendation for older adults from 0.8 to 1–1.2 
gram/kg body weight/day.  
Figure 6: Reasons for increased protein needs in the elderly. NNR 2012 recommends range in E%, 
target and corresponding g/kg bw 
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A high protein intake may have negative effects on kidney function, based on the 
observation that a high intake induces glomerular hyper-filtration with local glomerular 
hypertension, leading to glomerular damage. Chronic kidney disease (CKD) is usually 
the result of an underlying disease like diabetes, hypertension or glomerulonephritis. 
There is no evidence that protein per se could cause CKD. However, in patients with 
CKD a reduction to 0.6–0.8 gram protein/kg body weight/day may reduce glomerular 
stress, slow down the pace of kidney damage, and may postpone dialysis.  
Protein sources are many; i.e. red meat from beef and game, white meat from 
poultry, fish, dairy products and vegetables, e.g. legumes, nuts, bread etc. Recent 
evidence indicates that it’s mainly the intake of red meat that has negative effects on 
glomerular filtration rate (GFR), whereas a plant-based diet with even high intake of 
white meat and plant-derived proteins may be beneficial for kidney function. On the 
other hand, animal protein has a higher quality, i.e. a more muscle beneficial amino acid 
composition.  
It appears that for older people without CKD the risk of malnutrition and sarcopenia 
due to a too low protein intake is higher than the risk of CKD development due to high 
protein intake. Thus, for healthy older adults, protein recommendation could be 
maintained at 1–1.2 g/kg body weight/day. In older people with CKD (GFR <60 
ml/min/1.73m2) it could still be advisable to reduce protein intake to <0.8 g/kg body 
weight/day. 
4.4 What are the implications for NNR? Time for Q/A’s 
4.4.1 Q/A’s re extrapolation 
 Q: Do we know that the requirement for all nutrients is related to energy
expenditure? This might not be true for all nutrients. 
 A: You are exactly right. We cannot prove this is the case. We have energy
expenditure per organ in relation to total body weight, but we do not know 
whether nutrient requirements change proportionally to changes in energy 
expenditure. We simply do not have the data, unfortunately. One way to 
examine this, would be look at the activity of vitamin-depending enzymes in 
different organs and see how these change, but such data are also not 
available.  
4.4.2 Q/A’s re reference values for energy  
 Q: Sometimes you meet elderly people who eat relatively little food, but are not
losing weight. What is the explanation for this you think? Are these elderly in a
kind of starvation mode? 
 A: First of all, to make a correct judgement I would have to examine the foods
being consumed in the specific case and also examine the energy 
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expenditure. However, it is likely explained by the decrease in energy 
expenditure seen in elderly people. They therefore need less energy to 
maintain their body mass. There is a kind of adaptation occurring, where a 
new set point for the energy expenditure relative to the body mass is set.  
 Q: You mentioned that some foods might enable a change of white fat to brown
fat that could thereby increase energy expenditure. Can you elaborate a bit in
regards to this topic? 
 A: Some studies have shown that certain amounts and certain food 
ingredients can affect the sympathetic nervous system and lead to white fat 
being turned into beige or brown fat. This is a fascinating research topic, but 
there is still much to be learned.  
 Q: You mentioned that EFSA and also the NNR set an optimal BMI of 22.5 and 23
kg/m2, respectively. But in regards to the elderly this is challenging. Do we know
whether this is an optimal BMI also for the elderly?
 A: Correct, the given BMI values for the elderly might not be optimal since we
have very little data on older people, especially people that are 80+ years of 
age. We have used the BMI for younger people, but this is likely not optimal. 
Also, the concept of BMI does not take into account the body composition, 
which is also a very important aspect.  
4.4.3 Q/A’s re elderly and protein recommendations 
 Q: What about recent evidence suggesting that increased protein intake can lower
insulin sensitivity? 
 A: I am not too familiar with these studies, but one of the reasons why elderly
should consume adequate protein is to maintain muscle mass, which is also 
important for insulin sensitivity. The increased fat mass and decrease in 
muscle mass can likely increase the risk of insulin resistance. We do not 
propose high amounts of protein, we propose relatively minor increases in 
protein intake and we think that the benefits outweigh the potential 
negatives.  
 A: It could also be that it is the low intake of carbohydrates that is affecting 
insulin sensitivity and not the protein. It is difficult to figure out whether it is 
one or the other.  
 Q: Which clinical measurements did you primarily rely on when giving these
(higher, ed) protein recommendations for the elderly? 
 A: It was perhaps more a question of the protein intake needed for a lowering
of the risk factors. We have a number of different studies conducted in 
different settings showing that elderly people lose muscle mass at a lower 
protein intake. We also have studies showing that higher protein intake is 
beneficial for both muscle mass as well as muscle function.  
 Q: So muscle function is a good outcome to use when it comes to the elderly? 
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 A: Yes, definitely. The most important outcome in elderly is muscle function.  
 Q: Did you also use N-balancing studies where physical activity was taken into
account? 
 A: I have no experience with performing N-balancing studies myself. I do not
think that too many of such studies are done nowadays. To my knowledge, 
there are no N-balancing studies looking at physical exercise. They are all 
related to N-equilibrium.  
 Q: So did you measure muscle size and function in your studies? 
 A: Yes, we did both. Most importance was given to muscle function. 
 Q: It seems to me that some of the evidence was based on studies where protein
was not the only exposure. For instance, some of the studies also included intake
of vitamin D in addition to the protein. How did you determine whether it was
actually the protein that had an effect on muscle size and function? 
 A: Of course, in such studies it is difficult to tell what is affecting the outcome,
but not all studies were using mixed exposures. Some of the strongest 
evidence comes from observational studies where this should not be a large 
problem. But here we of course need to recognize the limitations of 
measuring food intake via FFQs. In addition to the observational data, we also 
have a number of short-term experimental studies showing a positive effect 
of both protein- and amino acid intake on protein synthesis. We know that 
one of the stronger anabolic stimuli of protein synthesis is protein intake, but 
it is also possible that some adaptation will occur after some days, so we 
cannot rely on short term studies only.  
 Q: Did you include any studies from the Nordic countries in your systematic
reviews? It looks as though a lot of the evidence comes from the U.S., but dietary
patterns might be quite different here in the Nordic countries? It might be that it
is the complete diet and not only the protein intake that influences muscle mass
and function in the elderly. 
 A: There were not too many studies from the Nordic countries. Most are from 
the U.S, and yes, dietary patterns are different. These are of course 
weaknesses that one needs to consider when interpreting the results.  
 Q: What about the frequency of protein intake, is that not important?
 A: We do not know for sure. There are some controversies regarding this
research question. There are some indications that you need 20–25 perhaps 
even 30 grams of protein per meal for an optimal stimulation of the protein 
synthesis. To be “safe”, you could space out your protein intake at the 
different meals and try to consume around 25–30 grams or so per meal. 
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5. Where do we go from here?
5.1 Options for Basing Dual Risk Assessment on Chronic Disease 
Endpoints 
Elizabeth A. Yetley, Ph.D. Retired, Sr. Nutrition Research Scientist, U.S. National 
Institutes of Health 
Historically, committees convened by the U.S. Institute of Medicine have used a dual 
risk assessment approach to determine Dietary Reference Intakes (DRIs) for both 
prevention of deficiencies and for definition of tolerable upper intake levels. These 
committees also prioritized the use of chronic disease endpoints for deriving DRIs.  
However, only 4 nutrients had sufficient evidence for considering chronic disease 
endpoints: saturated fat, trans fat, sodium, and fluoride. For trans and saturated fats, 
the threshold intake assumptions of the dual risk approach were not met and no DRI 
was provided. For sodium, an Adequate Intake (AI) reference value was based on 
practical considerations, not the dual risk model. A recent report recommended guiding 
principles for incorporating chronic disease endpoints into future DRI evaluations2. 
These principles address two questions: 1) is there a causal relationship between 
the nutrient and chronic disease(s), and, if so, 2) what is the nature of the quantitative 
intake-response curve? The first question has not been needed for reference values for 
prevention of nutrient deficiencies because their essentiality is generally considered 
“settled science”. A major challenge in evaluating causality for chronic disease 
endpoints is that the strongest evidence is generally derived from randomized 
controlled trials (RCTs), but there are limited numbers of RCTs for nutrition and chronic 
disease relationships. Surrogate disease markers in place of chronic disease outcomes 
lend themselves to RCT designs, but the process of “qualifying” surrogate markers has 
had only limited success with nutrients.  
2 The National Academies of Sciences, Engineering, Medicine. 2017. Guiding Principles for Developing Dietary Reference 
Intakes Based on Chronic Disease. The National Academies Press. Washington, DC 
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Box 2: Description of surrogate markers 
Surrogate marker: 
 Intended to substitute for a clinical endpoint; 
 Expected to accurately predict clinical benefit or harm.
Surrogate markers provide scientific and economic efficiencies: 
 Shorter duration; 
 Smaller sample sizes; 
 Lower costs.
If a causal relationship is found between a nutrient intake and a chronic disease risk, the 
second question is how best to quantify an intake-response curve? Evidence to support 
this question is often derived from observational studies. One challenge is that, unlike 
the linear intake-response curves observed for nutrient deficiencies and traditional 
upper intake levels, intake-response curves for nutrients and chronic diseases are often 
non-linear in nature.  
Moreover, they rarely exhibit the threshold effect seen with classical nutrient 
deficiencies. For this reason, the recent “Guiding Principles” report from the NAS 
recommends that intake reference values for chronic disease endpoints be based on 
intake ranges rather than on single point values.  
Box 3: List of publications on chronic disease endpoints 
I. Institute of Medicine. 2006.  Dietary Reference Intakes.  The Essential Guide to Nutrient 
Requirements. The National Academies Press. Washington, DC. 
https://www.nal.usda.gov/sites/default/files/fnic_uploads/DRIEssentialGuideNutReq.pdf 
II. Institute of Medicine.  2010. Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. 
The National Academies Press. Washington, DC. https://www.ncbi.nlm.nih.gov/books/NBK220297/ 
III.The National Academies of Sciences, Engineering, Medicine. 2017. Guiding Principles for
Developing Dietary Reference Intakes Based on Chronic Disease. The National Academies Press.  
Washington, DC. http://www.nationalacademies.org/hmd/Reports/2017/guiding-principles-for-
developing-dietary-reference-intakes-based-on-chronic-disease.aspx  
IV. Yetley EA, MacFarlane AJ, Greene-Finestone LS, Garza C, Ard JD, Atkinson SA, Bier DM, Carriquiry 
AL, Harlan WR, Hattis D, King JC, Krewski D, O’Connor DL, Prentice, RL, Rodricks JV, Wells GA. 2017.  
Options for basing Dietary Reference Intakes (DRIs) on chronic disease endpoints:  report from a joint 
US-/Canadian-sponsored working group. Am J Clin Nutr 105(Suppl):249S-85S. 
https://academic.oup.com/ajcn/article/105/1/249S/4569850 
V. Yetley EA, DeMets DL, Harlan WR Jr.  2017.  Surrogate disease markers as substitutes for chronic
disease outcomes in studies of diet and chronic disease relations.  Am J Clin Nutr 106(5):1175-1189. 
https://academic.oup.com/ajcn/article/106/5/1175/4822346 
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5.2 What are the implications for NNR? Time for Q/A’s 
 C: I would recommend that you also include relevant studies that make use of
Mendelian randomization. These studies can contribute important information
when trying to establish causal pathways between lipoproteins and cardiovascular
endpoints. This is also true for the so-called “natural studies” where certain areas
such as a specific country or municipality enforce a legislative restriction on trans-
fatty acids and where comparisons then can be drawn from changes in
cardiovascular disease outcomes. This has been done in, for instance, Denmark 
and in the state of New York.
 A: Yes, such studies were recognized, but it did not change our overall
assessment of the evidence between lipoproteins and cardiovascular disease. 
We acknowledge that surrogate measures can be complex. There can be 
multiple pathways. So there is still much to learn.  
 Q: Since chronic diseases are multifactorial I am surprised that you use a single
surrogate marker for assessing cardiovascular risk. You could use complex
surrogate markers instead where you take into account additional factors such as
inflammatory markers. 
 A: The more parameters you can measure the surer you are of course. It is
recommendable to measure multiple markers to better assess the risk. This 
will give you a more confident correlation. However, in order to use complex 
surrogate measures, we need to be able to explain multiple pathways. Often 
though, we still need a lot of knowledge on these pathways. 
 C: I think that more studies need to take into account the baseline status of the
investigated nutrients. This is not done often enough. You supplement these
groups without knowing their baseline levels. No surprise that some studies
therefore show different results. 
 A: Yes, accounting for nutrient status at baseline can be important.
 C: We probably have to carefully define the target population when looking at
surrogate markers. For instance, unmeasured baseline values can determine
whether or not you find an effect of the intervention. If these baseline values are
unaccounted for, it might be a problem.
 A: Yes, one of the important things is how you define your study population.
For example, if you only include healthy people in your study population, you 
have excluded half of the population. Therefore, you need to be very clear 
about the reasons for choosing your population and why the chosen 
population is a good fit for your study. Also, you need to be very clear about 
for whom the results are relevant.  
 Q: Is it possible to assess chronic disease markers in children? 
 A: With chronic disease markers you want to be careful in extrapolating
between different populations and we are missing a lot of data, for instance, 
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in regards to children, obese people, people with hypercholesterolemia and 
other subgroups of the population.  
 Q: You said that the concept of reference intervals could be difficult to interpret
for some users. Can you elaborate? 
 A: Yes, as a user, reference values can be difficult to interpret when they are
given as ranges. You have to consider this issue from a user perspective. 
Furthermore, when providing reference values in the form of a range, the 
food industry will tend to use the highest intake value and health 
professionals will use the lower intake value. 
 Q: Since a large part of the population is now obese should we concentrate on
making specific nutritional recommendations for obese individuals as their
requirements might be different, or should we concentrate on trying to prevent
people from becoming obese? 
 A: Prevention has so far not been successful and we are faced with a double
burden where a lot of overweight individuals also are deficient in several 
nutrients. The majority of our population is now overweight, so we have to 
consider this issue.  
 Q: In relation to nutritional recommendations, should we be considering the food 
matrix and the bioavailability of different nutrients when we are setting the
reference values? 
 A: Yes, even though this can be complex, we should try to include these
aspects also. This has to some extend also been considered in our current 
nutritional guidelines.  
5.3 Impressions of the day 
Rune Blomhoff, Professor, Department of Nutrition, Institute of Basic Medical Sciences, 
University of Oslo, Norway and project leader of a proposal for the 6th Edition of Nordic 
Nutrition Recommendations NNR2022 
Rune Blomhoff expressed the appropriateness of the symposium as it addressed 
several topics pertinent to a forthcoming update of the Nordic Nutrition 
Recommendations.  
Rune Blomhoff’s impression was that the terminologies in relation to dietary 
reference values was a specific challenge and reminded the audience that an 
international attempt for a global harmonization of methodological approaches to 
nutrient intake recommendations was currently undertaken by US FNB, WHO and 
FAO. The Nordic NNR work should follow this development closely.  
The workshop had contributed considerably to the scientific considerations in 
relation to dietary reference values by underlining the complexity of setting of the 
values and the needs and importance of cross-disciplinary collaboration. An important 
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lesson from the day was also the need to continuously address the specific Nordic 
challenges in relation to certain Nordic practices and specific nutrients.  
The presentations and discussions of the data – or rather the lack of data – and the 
various approaches to deal with the lack had been interesting and stimulated further 
thoughts. The needs for specific data for certain groups of the population, including the 
elderly had become very clear. Also, the presentation and the discussion in relation to 
markers of chronic diseases had been inspiring and useful for the future Nordic work on 
the common Nordic Nutrition Recommendations. 
5.4 Closing remarks 
Inge Tetens, Professor in Nutrition and Ageing, VITALITY – Centre for good older lives, 
Department of Nutrition, Exercise and Sports, University of Copenhagen, Denmark 
In her closing remarks, Inge Tetens expressed special thanks to the many excellent 
presentations from the invited experts and good discussions with participants during 
the day. She expressed confidence that the tasks of the symposium – to strengthen the 
capacity of the Nordic experts involved in the forthcoming review and update of the 
Nordic Nutrition Recommendations and to enhance the transparency of the dual risk 
assessment approach and methods applied – had been fully achieved. And it was her 
hope that the report to be published from the day would have a further reach to other 
nutrition colleagues and stakeholders.  
Finally, Inge Tetens thanked the Project group for excellent team work in the 
preparation of the symposium, the NKMT for its instrumental role in financing the 
symposium, and expressed appreciation to “Vitality – Centre for Good Older Lives” and 
the Faculty of Science, University of Copenhagen for facilitating the symposium at the 
Frederiksberg campus.  
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Sammendrag 
Nordisk samarbejde indenfor ernæringsområdet har en lang historie og inkluderer 
blandt andet udviklingen og opdateringer af de Nordiske Næringsstof Anbefalinger 
(NNR). Som en del af dette fortsatte arbejde og med finansiel støtte fra NKMT 
organiserede en nordisk projekt gruppe et symposium om den dobbelte risiko tilgang 
indenfor ernæringsområdet.  
Formålet med symposiet var at diskutere den nuværende brug af og nogle af de 
udfordringer, der ligger i at benytte en dobbelt risiko tilgang, når man fastsætter 
næringsstofanbefalinger – set i lyset af den forestående opdatering af de NNR.  
Som den første oplægsholder fastslog Inge Thorsdottir, IS, at konceptet med en 
dobbelt risiko tilgang indenfor ernæringsområdet stammede fra den potentielle risiko 
for et utilstrækkeligt indtag af næringsstoffer i den lave ende og et toksisk indtag af 
næringsstoffer i den høje ende af fordelingen af næringsstofindtag. Udviklingen af NNR 
igennem de sidste næsten 40 år afspejler den øgede opmærksomhed på, at et enkelt 
tal vedrørende gennemsnitligt næringsstofbehov ikke er tilstrækkeligt til at dække de 
forskellig behov for reference værdier, der både kan dække den lave og den høje ende 
af fordelingen af næringsstofindtag. 
Inge Tetens, DK, gav et overblik over den terminologi, der benyttes i de nordiske 
næringsstofanbefalinger, der på mange måder er mangen til de termer, der benyttes 
i andre lande, regioner og internationale agenturer – dog med nogle væsentlige 
forskelle. NNR anvender ikke udtrykket Tilstrækkeligt Indtag (AI) men anvender et 
Lavere Indtags Niveau (LI), der defineres anderledes end i andre referenceværdier. 
Det blev understreget, at der er et stort behov for harmonisering af disse 
terminologier. Anna Karina Lindroos, SE, diskuterede brugen af LI værdier i en 
nordisk sammenhæng og gav eksempler fra en vurdering af utilstrækkeligt indtag af 
udvalgte mikronæringsstoffer ved at benytte LI som cut-off point og argumenterede, 
at værdien ikke behøves på populationsniveau. Jan Alexander, NO, gav en oversigt 
over tolerabelt øvre indtagsniveau (UL), som er det maksimale indtag af et kronisk 
dagligt indtag af et næringsstof, som vurderes at være utilbøjelig til at lede til 
bivirkninger hos mennesker. UL værdier fastlægges for at beskytte befolkningen 
imod bivirkninger fra for højt indtag af mikronæringsstoffer. Eksempler på, hvorledes 
UL værdier sættes, blev giver for selen og D-vitamin igennem deres biologiske 
bivirkninger i relation til et stigende indtag. 
Som del af de udvalgte nuværende udfordringer indenfor den dobbelte risiko 
vurdering, der er særlig relevant for de nordiske lande, præsenterede Liisa Valsta, FI, 
data for brugen af kosttilskud, der er steget betydeligt indenfor de sidste par årtier i alle 
de nordiske lande. Sammenligninger mellem lande og bidraget af kosttilskud til det 
totale indtag af mikronæringsstoffer viste store forskelle mellem lande og indenfor 
lande. Lotte Høgberg, DK, gav en præsentation af et nyligt danske D-vitamin 
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forgiftningssituation blandt småbørn. Sagen demonstrerede et nationalt eksempel på 
en kollektiv risiko håndtering og illustrerede nogle af de lovgivningsmæssige 
udfordringer relateret til kosttilskud sammenlignet med registrerede lægemidler. 
Eksemplet demonstrerede ligeledes behovet for vel-etablerede kommunikationsveje 
imellem sundheds agenturer og sundhedssystemet. 
Jod er et næringsstof, som har modtaget øget videnskabelig opmærksomhed i de 
nordiske lande efter et systematisk review under den seneste opdatering af NNR2012 
viste, at jodstatus i de nordiske lande generelt ikke var vel-dokumenterede. Ingibjörg 
Gunnarsdottir, IS, og helle Margrethe Meltzer, NO, gav en oversigt over den nordiske 
situation og understregede, hvordan det nordiske samarbejde havde igangsat nye 
forsknings-aktiviteter with resultater, der viste, at mild jod mangel er til stede i 
forskellige befolkningsgrupper, herunder blandt gravide kvinder. 
Mangel på data som grundlag for at sætte referenceværdier for næringsstoffer blev 
adresseret. Hildegard Przyrembel, DE, forklarede, at ekstrapolation fra en gruppe til en 
anden ofte anvendes i forbindelse med fastsættelse af reference værdier. 
Ekstrapolation kan foretages i forhold til kropsvægt eller i relation til energiforbrug, 
hhv. isometrisk (lineær) eller allometrisk skalering. Anvendelsen af begge metoder blev 
diskuteret i relation til næringsstoffer.  
Nogle af de udfordringer, der er i forbindelse med at fastlægge referenceværdier 
for energi blev præsenteret af Monika Neuhaeuser-Berthold, DE. Trods variation i fysisk 
aktivitet varierer det daglige energiforbrug relativt lidt imellem individer, men varierer 
betydeligt imellem individer selv efter justering for krops-størrelse. En af de store 
udfordringer er at bestemme referenceværdier for energi for ældre personer, dels pga. 
mangel på data for energiforbrug ved hvile og dels for total energiforbrug blandt 
personer over 80 år. Ændringer i kropssammensætning med alderen er en særlig faktor, 
der kræver opmærksomhed og herunder at få kvantificeret den fysiske aktivitet, der er 
nødvendig for vedligeholdelse af muskelmasse. 
Tommy Cederholm, SE, gav en oversigt over proteinanbefalingerne for de ældre i 
NNR2012, hvor sygdomme også blev benyttet som kriterier for fastsættelse af 
reference værdier. Han argumenterede, at et lavt proteinindtag bidrager til en 
utilstrækkelig muskel re-modellering og muskel-tab, hvilket igen kan føre til sarkopeni. 
For at forebygge en sådan udvikling blev proteinanbefalingerne i NNR2012 øget for de 
ældre personer fra 0.8 til 1-1.2 gram/kg kropsvægt/dag. Det blev understreget, at et højt 
proteinindtag kan have negative effekter på nyrefunktion for visse grupper med 
underliggende sygdomme. 
Elizabeth Yetley, USA, gav et opsummering af, hvorledes komitéer, der var 
sammenbragt af det amerikanske Institut for Medicin, historisk havde benyttet en 
dobbelt risiko fastlæggelse tilgang til at fastlægge næringsstof reference værdier (DRI). 
I en nylig rapport blev der givet vejledende principper for, hvordan kroniske sygdomme 
vil kunne inddrages i fremtidige evalueringer af reference værdier, med 
nøglespørgsmål om, hvorvidt der er en kausal sammenhæng mellem næringsstoffer og 
kroniske sygdomme, og, hvis det er tilfældet, hvordan den kvantitative indtag-respons 
kurve ser ud. 
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Rune Blomhoff, NO, opsummerede sine indtryk fra dagen ved at udtrykke 
tilfredshed med det rettidige tidspunkt for afholdelsen af symposiet, da det 
adresserede emner, som er højst relevante for den forestående opgave med opdatering 
af de nordiske næringsstofanbefalinger. Han understregede behovet for harmonisering 
af terminologier og fremgangsmåde, de specielle nordiske udfordringer og de 
stimulerende tanker i relation til de tilgange, som benyttes for nærværende og de 
muligheder, der ligger for fremtiden.  
I sine afsluttende bemærkninger takkede Inge Tetens for de mange fremragende 
præsentationer fra de inviterede eksperter og gode efterfølgende diskussioner. Hun 
udtrykte tillid til, at symposiet havde opfyldt dets formål – at bidrage til at styrke 
kapaciteten blandt de nordiske eksperter, der er involveret i den forestående 
opdatering af NNR og til at øge gennemsigtigheden i det dobbelte risiko vurdering 
tilgang indenfor ernæringsområdet. 
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Appendix I: Program 
Wednesday 14 March 2018, Aud. A1-01.01, University of Copenhagen, Bulowsvej 17, 
Frederiksberg C, Denmark. 
 09:00–09:05: Welcome – Inge Tetens, DK.
Session one: The Dual Risk approach in Nutrition – The concept, terminologies and 
approaches. Chairs: Helle Margrete Meltzer & Hanna Eneroth.  
 09:05–09:15: Introduction to the Dual Risk concept in nutrition – Inga Thorsdottir, 
IS.
 09:15–09:35: Terminologies in nutritional risk assessment – Inge Tetens, DK.
 09:35–09:55: The approach and use of the lower level (LI) in the Nordic countries –
can we do without it? – Anna Karin Lindroos, SE. 
 09:55–10:15: The approach in setting the upper level (UL) – methodologies and 
issues to address – Jan Alexander, NO. 
 10:15–10:25: What are the implications for NNR? Time for questions and 
reflections – Moderators. 
 10:25–10:50: Coffee break.
Session two: Current challenges. Chairs: Inga Thorsdottir & Hanna Eneroth.  
 10:50–11:10: What are nutrient intakes from supplements vs intakes from diets in
the Nordic countries? – Liisa Valsta, FI. 
 11:10–11:30: Infants and vitamin D intoxication, recent outbreak in DK – Lotte CG
Høgberg, DK.
 11:30–11:50: Pregnancy/lactation and iodine, recent situation in Nordic countries –
Ingibjorg Gunnarsdottir, IS. 
 11:50–12:00: What are the implications for NNR? Time for questions and 
reflections – Moderators.
 12:00–13:00: Lunch.
Session three: Filling in the data gaps – extrapolations. Chairs: Liisa Valsta & Inge Tetens. 
 13:00–13:25: Extrapolations – allometric or isometric scaling? – Hildegard
Przymbel, DE. 
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 13:25–13:50: Challenges in setting reference values for energy – Monika
Neuhaeuser-Berthold, DE. 
 13:50–14:15: Elderly and protein recommendation – when disease endpoints are
also considered – Tommy Cederholm, SE. 
 14:15–14:30: What are the implications for NNR? Time for questions and 
reflections – Moderators. 
 14:30–14:55: Coffee break. 
Session four: Where do we go from here. Chairs: Liisa Valsta & Inge Tetens. 
 14:55–15:20: Options for basing dual risk assessment on chronic disease endpoints
– Elizabeth Yetley, US.
 15:20–15:50: Symposium Panel discussion: How can we use the dual risk approach
for the future NNR? Impressions of the day – Rune Blomhoff, NO, chair of the
upcoming NNR2022, followed by a Panel discussion with presenters of the day! –
Moderators. 
 15:50–16:00: Closing remarks – Inge Tetens, DK.
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Appendix II: List of participants 
Table 5: Participants at dual risk symposium March 14th, 2018 
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Appendix III: List of abbreviations 
A Answer 
AI Adequate Intake 
ALAT Parathyroid hormone 
AMDR Acceptable macronutrient distribution range 
ANR Average nutrient requirement 
AR Average requirement 
C Comment 
D-A-C-H Germany - Austria - Switzerland 
DHA Danish Health Authority 
DPIC Danish Poisons Information Centre 
DRI Dietary reference intake 
DRV Dietary reference value  
EAR Estimated average requirement 
FAO Food and Agriculture Organization 
FFQ Food frequency questionnaire 
FNB Food and Nutrition Board  
INL Individual nutrient level 
IoM Institute of Medicine 
LI Lower intake level 
LRNI Lower reference nutrient intake 
LTI Lover threshold intake 
NIV Nutrient intake value 
NNR Nordic Nutrition Recommendations 
PRI Population reference intake 
PTH Parathyroid Hormone 
Q Question 
RDA Recommended dietary allowance 
RI Recommended intake 
RI Recommended intake range for macronutrients 
RNI Reference nutrient intake 
UK United Kingdom 
UL Upper intake level 
UNL Upper nutrient level 
WHO World Health Organization 
The Dual Risk Approach in Nutrition
This report summarizes a Nordic symposium on the current use and 
challenges in applying a dual risk assessment approach in the setting of 
nutrition recommendations. The symposium is timed with respect to the 
forthcoming update of the Nordic Nutrition Recommendations (NNR). 
At the symposium invited experts addressed the methodological framework 
for the dual risk approach for setting nutrition recommendations, 
including the terminologies and the criteria for the assessment. Case 
studies were presented to underline some of the specific current Nordic 
challenges, including use of supplements. Especially, the lack of data for risk 
assessment in nutrition was addressed with examples on extrapolations to 
subgroups such as children and the elderly and to energy and protein. Also, 
the development of nutrition risk assessment using nutrient intakes and 
chronic disease endpoints was addressed.
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